ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

Por Orentas, Rimas J, Lopomo, Paola, Babbitt, William, Vigny, Marc, Mackall, Crystal L
Publicado em 2013

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)

Por Walker, Alec, Lopomo, Paola, Babbitt, William, Vigny, Marc, Mackall, Crystal, Orentas, Rimas
Publicado no J Immunother Cancer (2014)

Effective Deep Brain Stimulation Suppresses Low-Frequency Network Oscillations in the Basal Ganglia by Regularizing Neural Firing Patterns

Por McConnell, George C., So, Rosa Q., Hilliard, Justin D., Lopomo, Paola, Grill, Warren M.
Publicado em 2012

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Por Walker, Alec J., Majzner, Robbie G., Zhang, Ling, Wanhainen, Kelsey, Long, Adrienne H., Nguyen, Sang M., Lopomo, Paola, Vigny, Marc, Fry, Terry J., Orentas, Rimas J., Mackall, Crystal L.
Publicado no Mol Ther (2017)